(Q35522903)

English

Phase 1, open-label, dose escalation, safety, and pharmacokinetics study of ME-344 as a single agent in patients with refractory solid tumors

scientific article published on 19 November 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Phase 1, open-label, dose escalation, safety, and pharmacokinetics study of ME-344 as a single agent in patients with refractory solid tumors (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Johanna C Bendell

1

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Manish R Patel

2

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Jeffrey R Infante

3

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Carla D Kurkjian

4

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Suzanne F Jones

5

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Shubham Pant

6

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Howard A Burris

7

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Ofir Moreno

8

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Vanessa Esquibel

9

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Wendy Levin

10

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Kathleen N Moore

11

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

language of work or name

0 references

publication date

19 November 2014

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

121

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

1056-1063

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Oxidative stress and nerve damage: role in chemotherapy induced peripheral neuropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4406150

27 July 2018

A first-in-human dose-escalation study of ME-143, a second generation NADH oxidase inhibitor, in patients with advanced solid tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4406150

27 July 2018

Effects of mitochondrial poisons on the neuropathic pain produced by the chemotherapeutic agents, paclitaxel and oxaliplatin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4406150

27 July 2018

Defects in mitochondrial DNA replication and human disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4406150

27 July 2018

Mitochondrial dysfunction in ataxia-telangiectasia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4406150

27 July 2018

Targeting the mitochondria activates two independent cell death pathways in ovarian cancer stem cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4406150

27 July 2018

Aprataxin localizes to mitochondria and preserves mitochondrial function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4406150

27 July 2018

NV-128, a novel isoflavone derivative, induces caspase-independent cell death through the Akt/mammalian target of rapamycin pathway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4406150

27 July 2018

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4406150

27 July 2018

Characterization of acute and chronic neuropathies induced by oxaliplatin in mice and differential effects of a novel mitochondria-targeted antioxidant on the neuropathies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29155

21 January 2018

Identifiers

10.1002/CNCR.29155

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35522903&oldid=2143736311"